Michael has spent the last nineteen years in biotechnology building, leading and motivating process development and manufacturing teams to support clinical programs from early development to late stage clinical trials. Michael has been responsible for cellular and viral process development and analytics, cGMP manufacturing operations, CMC regulatory strategy, cellular procurement, and process characterization and validation activities for multiple novel viral, cell and gene therapy products. Currently, Michael is the Chief Operating Officer at ElevateBio, BaseCamp leading the operations team supporting a broad portfolio of gene and cell therapy products and technologies. Prior to Elevatebio, Michael was the Vice President of CMC operations at Oncorus working on the development of a next-generation oncolytic immunotherapy platform to treat cancer and bluebird bio as the Sr. Director of Technical Operations and Head of Cellular Process Development and Manufacturing Operations for all lentiviral vector-based autologous hematopoietic stem cell and CAR T cell programs.
This speaker appears at this event:
COO, ElevateBio BaseCamp, ElevateBio